Proximity Therapeutics
Cambridge, US · Founded 2021 · Delaware corporation
Founders & leadership
GE
GUILLERMO ELIASExecutive
SW
STEVEN W. TREGAYNamed on SEC filing
Board
JK
JULIUS KNOWLESBoard director
Reported raises · per SEC filings
Form D private placements$11M disclosed across 1 round · 2021
▶$11MraisedJan 2023 · 9 investors · BiotechnologyRule 506(b)
▶$11MraisedJan 2023 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- GUILLERMO ELIASExecutive Officer
- JULIUS KNOWLESDirector
- STEVEN W. TREGAYExecutive Officer, Director, Promoter
- Offering amount
- $11M
- Amount sold
- $11M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Proximity Therapeutics raised?
- Proximity Therapeutics has disclosed $11M raised across 1 round.
- Where is Proximity Therapeutics headquartered?
- Proximity Therapeutics is headquartered in Cambridge, US.